主题：作个记录，自北京时间220327起所看到的关于中医/新冠的报 -- 审度

我看了几眼，这里中医治疗新冠主要作为常规（西医）治疗的辅助手段出现的。

1. The experts agreed that the evidence evaluation reports applied appropriate and

rigorous methodology to determine the current level of clinical evidence and safety of

the studied TCM interventions used in the trials.

专家们一致认为，证据评估报告应用得当和强大的方法确定试验中使用的所研究的中医干预措施的当前临床证据水平和安全性。

2. The experts acknowledged that the included trials involved heterogeneous settings

and various types of patients and outcome measures.

专家们承认，纳入的试验涉及异质环境以及各种类型的患者和结果测量。

3. In addition to routine treatment, the results from the studied TCMs suggest that, on

the basis of clinically relevant outcome measures, the studied TCMs are beneficial in

the treatment of COVID-19, particularly in mild-to-moderate cases.

在常规治疗（应该指西医治疗）之余，所研究的中医结果表明，在临床相关结果测量的基础上，所研究的中医治疗有益于COVID-19 的治疗，特别是在轻度至中度病例中。

4. There are promising data to suggest that TCM is beneficial in reducing the risk of

progression from mild-to-moderate cases to severe COVID-19.

有乐观的数据表明，中医治疗有利于降低患者从轻度到中度病例进展为严重的 COVID-19的风险。

5. The evidence on the benefit of TCM injection for severe cases is limited, and further

evaluation is critically needed.

中药注射剂对重症病例有益的证据有限，进一步评估是非常必要的。

6. For mild-to-moderate cases, there is encouraging evidence that the studied TCMs,

when administered as add-on interventions to conventional treatment, may shorten

the time for viral clearance, resolution of clinical symptoms and length of hospital stay

when compared to conventional treatment alone.

对于轻度至中度病例，有令人鼓舞的证据表明，所研究的中医治疗，当作为常规治疗的附加干预措施进行使用时，可能会缩短清除病毒的时间、临床症状的消退和住院时间与单独的常规治疗相比。

7. The results of the TCM trials do not substantiate the use of any specific plant species

outside the general TCM framework in the context of COVID-19.

中医治疗试验的结果并未证实，在治疗COVID-19 时需要使用常规中医药范畴之外的使用任何特定的植物物种。

8. The studied TCM interventions given in addition to conventional treatment were well

tolerated and have a safety profile that is comparable to that of conventional

treatment alone.

结合常规治疗，所研究的中医干预措施具有良好耐受性并具有与单独进行常规治疗相当的安全性。

9. There is encouraging evidence that early application of TCM may result in better

clinical outcomes for patients with mild-to-moderate COVID-19.

有令人鼓舞的证据表明，早期应用中医可能会给轻度至中度 COVID-19 患者带来更好的临床结果。

10. Despite inherent limitations, the results from the selected RCTs justify further

investments in clinical trials to evaluate the potential benefits of selected TCMs in the

management of COVID-19.

尽管存在固有局限性，但所选 RCT 的结果表明进一步投资临床试验具有合理性，以评估选定的中医治疗在COVID-19 的治疗的潜在益处。